AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2017
Jan 5, 2017
33341_dirs_2017-01-05_9298e7b1-482c-4cec-b324-390db82cd99d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCIA/B)
CIK: 0000070487
Period of Report: 2017-01-04
Reporting Person: Jackson Steven D. (President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-01-04 | Employee Stock Option (right to buy) | $18.80 | A | 17608 | Acquired | 2027-01-04 | Class A Common Stock (17608) | Direct |
| 2017-01-04 | Employee Stock Option (right to buy) | $40.54 | A | 2935 | Acquired | 2027-01-04 | Class B Common Stock (2935) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 125983 | Direct |
| Class B Common Stock | 20997 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $15.23 | 2026-01-05 | Class A Common Stock (21535) | 21535 | Direct |
| Employee Stock Option (right to buy) | $34 | 2026-01-05 | Class B Common Stock (3589) | 3589 | Direct |
Footnotes
F1: This option becomes fully exercisable on January 5, 2021.
F2: This option becomes fully exercisable on January 4, 2022.
More from NATIONAL RESEARCH CORP
Regulatory Filings
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20